Tech Company Financing Transactions
Asuragen Funding Round
Private investors participated in a $7.5 million funding round for Asuragen. The round was announced on 3/21/2013.
Transaction Overview
Company Name
Announced On
3/21/2013
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2150 Woodward St. 100
Austin, TX 78744
USA
Austin, TX 78744
USA
Phone
Website
Email Address
Overview
Asuragen is a molecular diagnostics company using genomics to drive better patient management through best-in-class clinical testing solutions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew McManus
Chief Financial Officer
Lynne Hohlfeld
VP - Human Resources
Debra Thompson
VP - Operations
Bernard Andruss
VP - R & D
Gary Latham
Browse more venture capital transactions:
Prev: 3/21/2013: Omada Health venture capital transaction
Next: 3/21/2013: Wentworth Technology venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs